6
Oct
2026

RheaVita

Exhibitor at CPHI Milan 2026 stand 9D37, Machinery & Equipment
About Us

RheaVita markets an innovative continuous freeze-drying technology for (bio)pharmaceutical products. Our manufacturing approach saves you time and money, guarantees your product quality and offers your operations greater flexibility, compared to traditional batch freeze-drying. RheaVita sells single vial units for R&D, and full GMP systems.  RheaVita develops your freeze-drying process in a fast way with limited product consumption. We design the optimal formulation for your vaccines and biopharmaceuticals such as mRNA-LNPs, viral vectors, mAbs,...

  • Country/Region:
    Belgium
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Machinery and Equipment Supplier/Manufacturer
Primary activities
Technology
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 9D37, Machinery & Equipment

Products Featured at CPHI Milan 2026

  • RheaLyo GMP-Flex Freeze-Dryers

    Product RheaLyo GMP-Flex Freeze-Dryers

    RheaVita has turned pharmaceutical freeze-drying from a multi-day process into a fast, flexible, and agile process while guaranteeing quality at the individual product level. This is critical to delivering new therapeutics all over the world and making medicines more readily available. The GMP Continuous ...
  • RheaLyo Mono Freeze-Dryer

    Product RheaLyo Mono Freeze-Dryer

    The Single Vial Continuous Freeze-Drying System is specifically designed for R&D production based upon the RheaVita Continuous Freeze-Drying Technology. The equipment is perfectly suited for very fast formulation and process development and optimization using a very limited amounts of product by mimick...
  • Services offered

    Product Services offered

    1. Process development service: RheaVita has built deep knowledge to dry a broad range of biological products. We can design a spin freeze-drying recipe for your compounds in just a few days. 2. Formulation advice: RheaVita’s years of expertise and knowledge of biopharmaceutical stability and degradation a...

RheaVita Resources (1)

  • Whitepaper ADC

    Advancing ADC Lyophilization: The Value of RheaVita’s RheaLyo™ Continuous Freeze-Drying Technology for Antibody–Drug Conjugates (ADCs)